LivingLab Nanomedicine Network

LivingLab Nanomedicine is a public-private partnership initiated by Cytofind Diagnostics, Mercurna, TagWorks, FutureChemistry, PharmaCytics, Radboud University and Radboudumc. It currently consists of the following partners:

  • Drug Discovery & Drug Development: Radboud University; Radboudumc; Mercurna; Cytofind; Tagworks Pharmaceuticals. We are further connected to: Pivot Park Screening Centre; Charles River Laboratories; Protinhi Therapeutics; Okklo Life Sciences; Modiquest research; Modiquest Therapeutics; Synnafix.
  • Drug Delivery & Formulation: Pharmacytics; Radboudumc; Avivia. We are further connected to BioConnection.
  • Synthesis & Production: Radboud University; Future Chemistry; MercaChem; ChemConnection.
  • Diagnostics: Cytofind Diagnostics. We are further connected to: MDxHealth; SPL Medical; QM Diagnostics; TropIQ Health Sciences.
  • Nanomedicine Research Lab Facilities

LivingLab Nanomedicine is accessible to anyone involved in drug discovery & development, delivery, synthesis & production. The living lab is easily accessible and flexibly accessible for SMEs in order to accelerate developments in the field of nanomedicines.

We are always looking for additional partners who can strengthen our network. Interested? Please contact Radboud University for more information.

Contact details

Britta Driessen (Radboud Innovation)|  | M: +31 (0) 6 153 060 45

Antoine Wellink (Radboud Innovation Science) | | M: +31 (0) 6 520 282 26

Nano Medicine def versie drukwerk CMYKlogo's